Literature DB >> 17236170

Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.

M-T Sung1, M Wang, G T MacLennan, J N Eble, P-H Tan, A Lopez-Beltran, R Montironi, J J Harris, M Kuhar, L Cheng.   

Abstract

The histogenesis of sarcomatoid urothelial carcinoma, a rare neoplasm with bidirectional epithelial and mesenchymal differentiation, has been a matter of controversy. To clarify its origin, we analysed the status of X-chromosome inactivation in sarcomatoid urothelial carcinomas from 10 female patients and examined losses of heterozygosity (LOH) in these specimens and in additional 20 tumours from male patients. Six polymorphic microsatellite markers where genetic alterations occur frequently in early or advanced stages of urothelial carcinomas, including D3S3050, D8S261, IFNA, D9S177, D11S569 and TP53, were investigated in the current study. The identical pattern of non-random X-chromosome inactivation in both carcinomatous and sarcomatous components was identified in five of eight informative female patients, and the remaining three informative cases showed a random, but concordant, pattern of X-chromosome inactivation. The concordant X-chromosome inactivation results in all eight informative cases support the concept of a monoclonal origin of both components of this biphasic neoplasm. Among the tumours demonstrating loss of heterozygosity, high incidences of an identical pattern of allelic loss between carcinomatous and sarcomatous components were identified in genetic alterations associated with early carcinogenesis: 86% at D8S261, 78% at D11S569, 75% at D9S177 and 57% at IFNA. In contrast, concordant LOH patterns were less frequently observed for microsatellites related to advanced carcinogenesis: only 40% at D3S3050 and 40% at TP53. The significant overlap of loss of heterozygosity supports a monoclonal cell origin and suggests that clonal divergence may occur during tumour progression and differentiation. Divergent patterns of discordant allelic loss of microsatellite markers imply that heterogeneous pathogenetic pathways may exist in the evolution of this enigmatic neoplasm. Copyright (c) 2007 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2007        PMID: 17236170     DOI: 10.1002/path.2129

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

1.  Divergent squamous differentiation in upper urothelial carcinoma-comparative clinicopathological and molecular study.

Authors:  Ljubinka Jankovic Velickovic; Zana Dolicanin; Takanori Hattori; Ivana Pesic; Biljana Djordjevic; Mariola Stojanovic; Jablan Stankovic; Milan Visnic; Vladisav Stefanovic
Journal:  Pathol Oncol Res       Date:  2010-12-02       Impact factor: 3.201

2.  Sarcomatoid carcinoma of the urinary bladder: a clinicopathological study of 4 cases and a review of the literature.

Authors:  Konstantinos Stamatiou; Nikolaos Galariotis; Ioannis Michailidis; Nerantzoula Petrakopoulou; Helen Moustou; Adamantia Zizi-Sermpetzoglou
Journal:  Korean J Urol       Date:  2010-10-21

3.  Laser capture microdissection in the genomic and proteomic era: targeting the genetic basis of cancer.

Authors:  Barbara Domazet; Gregory T Maclennan; Antonio Lopez-Beltran; Rodolfo Montironi; Liang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2008-03-15

4.  [Non-invasive and invasive urothelial tumours: special challenges in uropathological diagnostics].

Authors:  N T Gaisa; K Lindemann-Docter
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

5.  Spindle cell carcinoma progressed from transitional cell carcinoma of the urinary bladder.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

6.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

7.  Evidence for colorectal sarcomatoid carcinoma arising from tubulovillous adenoma.

Authors:  Jeffrey-K Lee; Pradipta Ghosh; Valerie McWhorter; Misty Payne; Ryan Olson; Mary-L Krinsky; Sonia Ramamoorthy; John-M Carethers
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

8.  Urothelial carcinoma of the sarcomatoid variant in a young patient with spina bifida: a case report and review of the literature.

Authors:  Michael Nomikos; Prodromos Philippou; Chrysa Glava; Dimitrios Delakas
Journal:  Cases J       Date:  2009-12-22

9.  Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing.

Authors:  Alberto Paniz-Mondolfi; Rajesh Singh; George Jour; Mandana Mahmoodi; A Hafeez Diwan; Bedia A Barkoh; Ronald Cason; Yve Huttenbach; Gustavo Benaim; John Galbincea; Rajyalakshmi Luthra
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

10.  Urinary bladder carcinoma with triplicate differentiations into giant cell sarcomatoid carcinoma, squamous cell carcinoma, and papillary urothelial transitional cell carcinoma: a case report.

Authors:  Tadashi Terada
Journal:  Cases J       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.